Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $418.8M | $385.1M | $354.3M | $335.6M | $286.1M | $243.5M | $208.5M |
| Gross profit | $257.7M | $230.6M | $213.3M | $203.1M | $174.5M | $142.8M | $128.7M |
| Gross margin | 61.53% | 59.88% | 60.20% | 60.50% | 60.99% | 58.62% | 61.74% |
| Research & development | $41.0M | $37.1M | $34.2M | $28.2M | $20.4M | $19.6M | $11.6M |
| Operating expenses | $236.7M | $232.4M | $254.1M | $170.5M | $160.9M | $167.2M | $109.1M |
| Operating income | $21.0M | −$1.7M | −$40.8M | $32.5M | $13.6M | −$24.4M | $19.6M |
| Operating margin | 5.02% | −0.45% | −11.51% | 9.69% | 4.75% | −10.03% | 9.41% |
| EBITDA | $96.2M | $66.3M | $15.3M | $34.3M | $15.7M | −$22.0M | $22.2M |
| EBITDA margin | 22.96% | 17.21% | 4.32% | 10.20% | 5.49% | −9.02% | 10.65% |
| Net income | −$1.6M | −$12.1M | −$55.4M | $14.7M | −$13.3M | −$49.4M | −$8.9M |
| Net profit margin | −0.38% | −3.13% | −15.62% | 4.39% | −4.64% | −20.28% | −4.28% |
| Basic EPSper basic share | -$0.01 | -$0.08 | -$0.35 | $0.09 | -$0.09 | -$0.37 | -$0.07 |
| Diluted EPSper diluted share | -$0.01 | -$0.08 | -$0.35 | $0.09 | -$0.09 | -$0.37 | -$0.07 |
Reported shareholders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 12.34%18.82M shares |
DEERFIELD MANAGEMENT COMPANY, L.P. | 4.93%7.51M shares |
Haveli Investment Management LLC | 4.85%7.4M shares |
Jefferies Financial Group Inc. | 4.65%7.09M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 4.63%7.06M shares |
DIMENSIONAL FUND ADVISORS LP | 3.95%6.02M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.46%5.28M shares |
STATE STREET CORP | 3.16%4.82M shares |
WASATCH ADVISORS LP | 2.82%4.3M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.06%3.14M shares |
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 1.88%2.86M shares |
ROYCE & ASSOCIATES LP | 1.81%2.76M shares |
UBS Group AG | 1.75%2.67M shares |
MILLENNIUM MANAGEMENT LLC | 1.68%2.56M shares |
MORGAN STANLEY | 1.67%2.55M shares |
FIRST TRUST ADVISORS LP | 1.59%2.42M shares |
Feehery William F | ≈1.55%2.36M shares |
AQR CAPITAL MANAGEMENT LLC | 1.42%2.16M shares |
AMERIPRISE FINANCIAL INC | 1.33%2.03M shares |
T. Rowe Price Investment Management, Inc. | 1.31%2M shares |
Percentages use 152.5M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 11, 2025Form 4 | Feehery William FCHIEF EXECUTIVE OFFICER | BuyCommon Stock | 24.1K | $8.30 | $200.0K | 2.36M |
| Sep 9, 2025Form 4 · 10b5-1 | Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF | SellCommon Stock | 51.2K | $10.92 | $559.4K | 74.0K |
| Oct 7, 2024Form 4 · 10b5-1 | SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS | SellCommon Stock | 5.4K | $11.03 | $59.7K | 50.1K |
| Sep 9, 2024Form 4 · 10b5-1 | Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF | SellCommon Stock | 51.2K | $11.29 | $578.3K | 99.7K |